Skip to content

Psychological Interventions to Prevent Late Effects in Breast Cancer

Pre- and Post-operative Psychological Interventions to Prevent Pain and Fatigue After Breast Cancer Surgery: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04518085
Acronym
PREVENT
Enrollment
203
Registered
2020-08-19
Start date
2020-10-01
Completion date
2023-11-01
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Fatigue, Pain, Postoperative

Keywords

Breast cancer, Post-surgical pain, Fatigue, Hypnosis, Acceptance and commitment therapy

Brief summary

The study aims to investigate whether a combined pre-operative medical hypnosis plus a post-operative internet-based acceptance and commitment intervention are more effective in preventing post-surgical pain and fatigue following breast cancer surgery compared with pre-operative mindfulness plus treatment as usual.

Detailed description

The trial will include 200 patients undergoing breast cancer surgery at Oslo University Hospital. The patients will be randomized into two groups. One group will receive a 20 minute pre-surgical hypnosis session delivered by an experienced clinical psychologist plus a post-surgical internet-based acceptance and commitment intervention. The control group will receive a 20 minute pre-surgical mindfulness session delivered through an audio recording plus treatment as usual. The primary outcomes of the study are quantitative measures of post-surgical pain and fatigue. In addition, relationships between biomarkers of stress and subacute post-surgical pain and fatigue will be analyzed using using blood- and hair samples. The study uses a longitudinal design with baseline measures obtained pre-surgery and follow up measures obtained 3 and 12 months post-surgery.

Interventions

Single session 20 minutes hypnosis session originally developed and tested by Montgomery et al. (2007) in a similar setting. Delivered by an experienced clinical psychologist.

BEHAVIORALInternet-based Acceptance and Commitment Therapy (iACT)

Access to an online platform developed to this study containing video clips and audio files with ACT consistent material

Single session mindfulness session delivered by audio file

BEHAVIORALTreatment as Usual (TAU)

Treatment as usual as part of post-surical care

Sponsors

Oslo University Hospital
CollaboratorOTHER
University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The intervention group vs. active control group status will be known to the participants and the health care personnel delivering the interventions. However, the investigator, outcome assessor and the additional health care personnel at the unit will be masked to the conditions.

Intervention model description

Randomized Controlled Trial, in which participants are randomly allocated to either the intervention group or an active control group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Women diagnosed with breast cancer and scheduled for surgery * Be able to provide informed consent

Exclusion criteria

* Insufficient Norwegian speaking or writing skills to participate in the interventions and fill out questionnaires * Cognitive and psychiatric impairment * Other serious malignancies

Design outcomes

Primary

MeasureTime frameDescription
Chronic post-surgical pain3 months after surgeryMeasured through a Numeric Rating Scale (NRS) for pain intensity. The scale ranges from 0-10, anchored by verbal descriptors at either end of the scale where 0 is no pain at all and 10 is the worst possible pain.
Post-surgical fatigue3 months after surgeryMeasured through the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue subscale (FACIT-F) which is a unidimensional self-report scale to assess fatigue and its impact on daily life. The score range is 0-52 where a higher score indicates better quality of life (i.e. less symptoms and disability)

Secondary

MeasureTime frameDescription
Number of psychotropic and pain-related prescriptions3 and 12 months post-surgeryUsage of psychotropic and pain medication obtained through registry data from the Norwegian Prescription Database at 3 and 12 months follow-up. Number of prescriptions will be summarized and compared between intervention and control group.
Number of sick leave days3 and 12 months post-surgeryDays away from work on sick leave will be measured through registry data
Pain intensity, pain unpleasantness, fatigue, nausea, physical discomfort and emotional upsetOn the day of surgery right before dischargeMeasured by a Visual Analogue Scale (VAS) (to replicate a previous hypnosis trial - Montgomery et al 2007). The range is 0-100 where a higher score indicates more intense symptoms.
Psychological distress3 and 12 months post-surgeryMeasured through the Hospital Anxiety and Depression Scale (HADS). The total score ranges from 0-42, where a higher score indicates more symptoms
Psychological flexibility3 and 12 months post-surgeryMeasured through the Acceptance and Action Questionnaire (AAQ-II). The scale ranges from 7-49, where higher score indicates more psychological inflexibility
Stress (immunological) reactivityBaseline (pre-surgery) plus 4 weeks post-surgery (Cortisol will only be measured at baseline)Immune function is assessed through whole blood samples using the standardized TruCulture system that contains immunogenic stimuli (infected tubes). This test will reveal the induced innate and adaptive immune response in whole blood after stimulation with LPS, by quantifying the release of soluble immune activation products (cytokines, chemokines, soluble receptors etc.) in the supernatant and by measuring the transcription level (mRNA) in the circulating blood (immune) cells.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026